文献速递儿科与产科急症呼吸衰竭与机械通气

加速COVID-19二价加强针接种与美国儿科住院及缺课估计的关联

Estimated US Pediatric Hospitalizations and School Absenteeism Associated With Accelerated COVID-19 Bivalent Booster Vaccination.
PubMed 文献 · JAMA Netw Open · 2023-05-01
一句话结论决策分析模型提示,加速二价加强针接种至流感疫苗水平可减少儿科住院和缺课,但为模型估计而非前瞻验证。

该决策分析模型将COVID-19传播模型拟合2020年10月1日至2022年9月30日报告发病率数据,模拟2022年10月1日至2023年3月31日结局。模拟加速二价加强针接种至2020-2021季节性流感疫苗年龄别接种水平或其一倍,评估0-17岁儿童住院、ICU入住、隔离天数及5-17岁缺课天数。结果显示较高接种水平可避免约1009万儿科住院(其中2645例需ICU)和约545万缺课天数。作者认为尽管COVID-19预防策略常关注老年人群,儿童加强针运动的获益可能 substantial。

要点

  • 模拟接种至流感疫苗年龄别水平:0-17岁避免10019例住院(95%CrI 8756-11278),其中2645例需ICU(95%CrI 2152-3147)。
  • 模拟接种至流感疫苗年龄别水平:5-17岁避免5448694天缺课(95%CrI 4936933-5957507)。
  • 模拟接种至流感疫苗年龄别水平50%:0-17岁避免5791例住院(95%CrI 4391-6932),其中1397例需ICU(95%CrI 846-1948)。
  • 模拟接种至流感疫苗年龄别水平50%:5-17岁避免2875926天缺课(95%CrI 2524351-3332783)。
  • 作者认为儿童加强针运动的获益可能 substantial,尽管COVID-19预防策略常关注老年人群。

适用人群与场景

  • 传播模型纳入全美年龄分层人群;结局模型纳入18岁以下儿童。
  • 缺课结局评估5-17岁儿童;住院、ICU入住和隔离天数评估0-17岁儿童。
  • 模拟场景为加速二价COVID-19加强针接种运动,目标接种率分别为2020-2021季节性流感疫苗年龄别接种水平的一半或相似水平,覆盖所有年龄组符合条件人群。

研究设计与关键结果

  • 研究类型:决策分析模型,将COVID-19传播模型拟合2020年10月1日至2022年9月30日报告发病率数据,结局模拟2022年10月1日至2023年3月31日。
  • 模拟接种至流感疫苗年龄别水平:5-17岁避免5448694天缺课(95%CrI 4936933-5957507);0-17岁避免10019例住院(95%CrI 8756-11278),其中2645例需ICU(95%CrI 2152-3147)。
  • 模拟接种至流感疫苗年龄别水平50%:5-17岁避免2875926天缺课(95%CrI 2524351-3332783);0-17岁避免5791例住院(95%CrI 4391-6932),其中1397例需ICU(95%CrI 846-1948)。
  • 作者结论: eligible年龄组二价加强针接种率增加与儿科住院和缺课减少相关;儿童加强针运动的获益可能 substantial,尽管COVID-19预防策略常关注老年人群。

证据类型、等级与局限

  • 证据类型:决策分析模型(模拟研究)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,尽管COVID-19预防策略常关注老年人群,儿童加强针运动的获益可能 substantial。
  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Adverse outcomes of COVID-19 in the pediatric population include disease and hospitalization, leading to school absenteeism. Booster vaccination for eligible individuals across all ages may promote health and school attendance.

OBJECTIVE: To assess whether accelerating COVID-19 bivalent booster vaccination uptake across the general population would be associated with reduced pediatric hospitalizations and school absenteeism.

DESIGN, SETTING, AND PARTICIPANTS: In this decision analytical model, a simulation model of COVID-19 transmission was fitted to reported incidence data from October 1, 2020, to September 30, 2022, with outcomes simulated from October 1, 2022, to March 31, 2023. The transmission model included the entire age-stratified US population, and the outcome model included children younger than 18 years.

INTERVENTIONS: Simulated scenarios of accelerated bivalent COVID-19 booster campaigns to achieve uptake that was either one-half of or similar to the age-specific uptake observed for 2020 to 2021 seasonal influenza vaccination in the eligible population across all age groups.

MAIN OUTCOMES AND MEASURES: The main outcomes were estimated hospitalizations, intensive care unit admissions, and isolation days of symptomatic infection averted among children aged 0 to 17 years and estimated days of school absenteeism averted among children aged 5 to 17 years under the accelerated bivalent booster campaign simulated scenarios.

RESULTS: Among children aged 5 to 17 years, a COVID-19 bivalent booster campaign achieving age-specific coverage similar to influenza vaccination could have averted an estimated 5 448 694 (95% credible interval [CrI], 4 936 933-5 957 507) days of school absenteeism due to COVID-19 illness. In addition, the booster campaign could have prevented an estimated 10 019 (95% CrI, 8756-11 278) hospitalizations among the pediatric population aged 0 to 17 years, of which 2645 (95% CrI, 2152-3147) were estimated to require intensive care. A less ambitious booster campaign with only 50% of the age-specific uptake of influenza vaccination among eligible individuals could have averted an estimated 2 875 926 (95% CrI, 2 524 351-3 332 783) days of school absenteeism among children aged 5 to 17 years and an estimated 5791 (95% CrI, 4391-6932) hospitalizations among children aged 0 to 17 years, of which 1397 (95% CrI, 846-1948) were estimated to require intensive care.

CONCLUSIONS AND RELEVANCE: In this decision analytical model, increased uptake of bivalent booster vaccination among eligible age groups was associated with decreased hospitalizations and school absenteeism in the pediatric population. These findings suggest that although COVID-19 prevention strategies often focus on older populations, the benefits of booster campaigns for children may be substantial.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Fitzpatrick MC, Moghadas SM, Vilches TN, et al. Estimated US Pediatric Hospitalizations and School Absenteeism Associated With Accelerated COVID-19 Bivalent Booster Vaccination. JAMA Netw Open. 2023. PMID: 37204795. doi:10.1001/jamanetworkopen.2023.13586

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。